Use of ambroxol for the treatment of rhinovirus infections

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/137 (2006.01) A61P 31/16 (2006.01)

Patent

CA 2619863

The invention is directed to the use of ambroxol or pharmaceutically acceptable salts thereof for preparing a medical composition for treating or preventing infections caused by human rhinovirus. Surprisingly it was found that Ambroxol is capable to suppress the replication of human rhinovirus. Therefore, the ambroxol-containing medical composition is suitable to treat or prevent against all symptoms of a rhinovirus infection and provides a direct antivirale effect.

La présente invention concerne l'utilisation d'ambroxol ou de sels pharmaceutiquement acceptables de ce dernier pour préparer une composition thérapeutique utile pour traiter ou pour prévenir les infections provoquées par le rhinovirus humain. On a découvert avec surprise que l'ambroxol est capable de supprimer la réplication du rhinovirus humain. Par conséquent, une composition thérapeutique contenant de l'ambroxol est appropriée pour traiter ou pour prévenir tous les symptômes d'une infection à rhinovirus et assure un effet antiviral direct.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of ambroxol for the treatment of rhinovirus infections does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of ambroxol for the treatment of rhinovirus infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ambroxol for the treatment of rhinovirus infections will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2054018

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.